Cinnarizine vs. topiramate for migraine prophylaxis in children: a randomized, double-blind, parallel-group clinical trial.

BMC Neurol · 2026 · PMC13196016 · PMID 42106656

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Appetite reduction was numerically more frequent in the topiramate group, consistent with its known side-effect profile, but the difference did not reach statistical significance in this sample.

also in 111,027 other papers

a numerical trendno p-value reported

In contrast, cinnarizine showed a numerical trend toward a lower incidence of appetite reduction compared with topiramate (4.2% vs. 14.6%).

also in 1,012 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.